Andelyn Biosciences

Activities: Manufacturing Research & Development

Andelyn Biosciences is a full-service cell and gene therapy CDMO focused on the development, characterization and production of viral vectors for gene therapy. With more than 20 years of experience, Andelyn’s deep scientific expertise has resulted in the production of cGMP material for more than 450 clinical batches and 75 global clinical trials.

Visit website

Profile

Operating out of its development and manufacturing facilities in Columbus, Ohio, Andelyn supports its clients in developing cell and gene therapies from concept through plasmid engineering and manufacturing, process and analytical development, and cGMP clinical and commercial manufacturing. Andelyn can accelerate programs and deliver high quality products by developing and manufacturing processes on its configurable, data-driven AAV Curator® Platform, or tech transferring in an established client program. Capabilities include cGMP manufacturing for suspension processes up to a 2,000-liter and adherent processes. A rigorous quality system, regulatory support, and supply chain vertical integration further support clients in bringing their critical therapies to market.

Trending Articles

  1. Sharp's emissions reduction targets validated by Science Based Targets initiative Sharp, a leader in pharmaceutical packaging, clinical trial supply services and small-scale sterile manufacturing, announces that its near-term and long-term greenhouse gas...
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Wound care at a crossroads: precision manufacturing meets a growing global need The wound care market is undergoing a quiet transformation. Although headlines often focus on breakthrough drugs or cutting-edge wearables, the evolution of wound dressings and...
  3. Gerresheimer achieves leadership status with A- CDP score Sustainability progress earns strong rating for climate disclosure and emissions strategy
  4. Denny Bros celebrates 80 years in business Hugely proud of its Bury St Edmunds heritage, family values and commitment to the environment, Denny Bros has been a local business institution for an impressive 80 years
  5. Qureight analyses of Insilico Medicine’s Phase IIa rentosertib data support preliminary efficacy results and future trial expansion Qureight’s deep-learning image biomarkers and clinical data analytics platform used to analyse enrolled idiopathic pulmonary fibrosis (IPF) patient data, supporting efficacy...

Upcoming event

POWTECH

23-25 September 2025 | Exhibition | Nuremberg, Germany See all

Related Content

Cell & Gene Therapy

The challenges and trends in gene therapy

Three perspectives on the challenges and trends in gene therapy
Manufacturing

Andelyn Biosciences adds Stanton Lab CNS Capsids to AAV Curator Platform

Andelyn Biosciences expands AAV Curator® Platform offering to include Stanton Lab CNS Capsids through a license agreement from the Broad Institute of MIT and Harvard
Cell & Gene Therapy

Andelyn Biosciences produces viral vector for Nationwide Children’s Hospital using AAV Curator Platform

Andelyn Biosciences AAV Curator® Platform used to manufacture clinical grade viral vector for FDA-Authorised first-in-world Universal Donor CRISPR/AAV Transduced CAR-NK cells
Cell & Gene Therapy

Andelyn applies AAV Curator to treat ultra-rare NEDAMSS patient

Andelyn Biosciences applies the AAV Curator platform to deliver novel gene therapy for an ultra-rare NEDAMSS disease patient 14-months after diagnosis
Manufacturing

Andelyn Biosciences manufactures AAV for NCH's cell therapy and cancer immunology programme

The viral vector will be a constituent of a novel cell therapy designed to treat patients with aggressive blood cancers such as acute myeloid leukaemia (AML)
Manufacturing

Andelyn Biosciences and Broad Institute of MIT and Harvard expand CGT R&D partnership

The CDMO's AAV Curator Platform will now incorporate the Broad Institute's Stanton Lab CNS capsids, which are up to 6x more effective at targeting most areas of the cerebrum
Manufacturing

Hubble Therapeutics selects Andelyn Biosciences to manufacture its AAVs

The CDMO will be responsible for the manufacture of adeno-associated viruses in order to treat leber congenital amaurosis 16
Subscribe now